CoChat

Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies

Lettre, Guillaume, Bauer, Daniel E · 2016 · The Lancet

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Abstract

Sickle-cell disease affects millions of individuals worldwide, but the global incidence is concentrated in Africa. The burden of sickle-cell disease is expected to continue to rise over the coming decades, adding to stress on the health infrastructures of many countries. Although the molecular cause of sickle-cell disease has been known for more than half a century, treatment options remain greatly limited. Allogeneic haemopoietic stem-cell transplantation is the only existing cure but is limited to specialised clinical centres and remains inaccessible for most patients. Induction of fetal haemoglobin production is a promising strategy for the treatment of sickle-cell disease. In this Series paper, we review scientific breakthroughs in epidemiology, genetics, and molecular biology that have brought reactivation of fetal haemoglobin to the forefront of sickle-cell disease research. Improved knowledge of the regulation of fetal haemoglobin production in human beings and the development of genome editing technology now support the design of innovative therapies for sickle-cell disease that are based on fetal haemoglobin.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)01341-0

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 125 references

Research works printed but not linked: 1

  1. Canver, 2015, BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis, Nature, 527, 192, 10.1038/nature15521 · DOI · Paper page

Cited by

See all 115

Metadata

Authors
Lettre, G., & Bauer, D. E.
Affiliations
  • Montreal Heart Institute (CA)
  • Boston Children's Hospital (US)
Corresponding author
  • Lettre, Guillaume
  • Bauer, Daniel E
Venue
The Lancet
Publisher
Elsevier BV
Published
2016-06
Volume
387
Issue
10037
Pages
2554-2564
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2440679555
Cited by
104
References
123
Citations by year
2026: 3 · 2025: 10 · 2024: 17 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 12
FWCI
8.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research (MOP #123382)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK093705)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
sickle cell disease, fetal hemoglobin, genetic epidemiology, hemoglobinopathies, genome editing, hematopoietic stem cell transplantation, sickle cell disease treatment
MeSH terms
Anemia, Sickle Cell, Animals, Carrier Proteins, Chromatin, Fetal Hemoglobin, Humans, Nuclear Proteins, Repressor Proteins, Transcription, Genetic, Gene Deletion, Polymorphism, Single Nucleotide, Mice, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies. https://app.cochat.ai/papers/10.1016/s0140-6736(15)01341-0
The paper
Lettre, G., & Bauer, D. E. (2016). Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies. The Lancet. https://doi.org/10.1016/s0140-6736(15)01341-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.